Ruibin Xi

17.5k citations
53 papers · 2.1k indexed · h-index 22
Topics
Cancer Genomics and Diagnostics (22 papers)Genomic variations and chromosomal abnormalities (15 papers)Single-cell and spatial transcriptomics (9 papers)

In The Last Decade

Ruibin Xi

50 papers receiving 2.0k citations

Peers

Ruibin Xi
Comparison fields: 5 of 138
  • Molecular Biology 1.1k
  • Cancer Research 639
  • Genetics 481
  • Oncology 307
  • Immunology 226
Replace Wessel N. van Wieringen with:
Wessel N. van Wieringen Netherlands
Shili Lin United States
Anna Bergamaschi United States
Veerabhadran Baladandayuthapani United States
David Verbel United States
Tarek G. Gharib United States
Lana X. Garmire United States
Bradley M. Broom United States
Javad Beheshti United States
Fei Yang China
Ruibin Xi relative to Wessel N. van Wieringen Netherlands Wessel N. van Wieringen's profile →
Citations per field
00.5×1.5×2.4×
Wessel N. van Wieringen · 1×
Citations per year

Countries citing papers authored by Ruibin Xi

Since Specialization
Citations

This map shows the geographic impact of Ruibin Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruibin Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruibin Xi more than expected).

Fields of papers citing papers by Ruibin Xi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruibin Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruibin Xi. The network helps show where Ruibin Xi may publish in the future.

Co-authorship network of co-authors of Ruibin Xi

This figure shows the co-authorship network connecting the top 25 collaborators of Ruibin Xi. A scholar is included among the top collaborators of Ruibin Xi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruibin Xi. Ruibin Xi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 1
4 5
5 6
6 0
7 15
8 9
9 21
10 6
11 40
12 114
13 53
14 71
15 29
16 289
17 7
18 211
19 103
20 39

About Ruibin Xi

Ruibin Xi is a scholar working on Cancer Research, Genetics and Signal Processing, having authored 53 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (22 papers), Genomic variations and chromosomal abnormalities (15 papers) and Single-cell and spatial transcriptomics (9 papers). The work is most often cited by research in Cancer Research (639 citations), Statistics and Probability (215 citations) and Genetics (481 citations). Ruibin Xi has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Peter J. Park, Tae‐Min Kim, Lovelace J. Luquette, Nan Lin, Nan Lin, Qing Li, Mark D. Johnson, Raju Kucherlapati, Yuchao Xia and Semin Lee. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026